CI 924

TargetMol
Product Code: TAR-T30917
Supplier: TargetMol
CodeSizePrice
TAR-T30917-5mg5mg£850.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T30917-50mg50mg£1,661.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T30917-100mg100mg£2,079.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
Prices exclude any Taxes / VAT

Overview

Regulatory Status: RUO
Shipping:
cool pack
Storage:
-20℃

Images

1 / 1

Further Information

Bioactivity:
CI 924 is a lipid-lowering drug. CI 924 increased anti-atherosclerotic HDL and decreased VLDL at 600 mg/day.
CAS:
79520-77-7
Formula:
C26H34O6
Molecular Weight:
442.552
Purity:
0.98
SMILES:
CC(C)(CCCOc1ccc(OCCCC(C)(C)C(O)=O)c(c1)-c1ccccc1)C(O)=O

References

1. Harbarth S, Szucs T, Berger K, Jilg W. The economic burden of hepatitis B in Germany. Eur J Epidemiol. 2000 Feb;16(2):173-7. PubMed PMID: 10845268. 2. Hofstra AH, King LM, Walker RM. Early effects of CI-924 on hepatic peroxisome proliferation, microsomal enzyme induction, PCNA, and apoptosis in B6C3F1 mice and Wistar rats. Arch Toxicol. 1997;71(4):250-7. PubMed PMID: 9101042. 3. Walker RM, Wojcinski ZW, Hofstra AH, King LM, Rogers JE, Baker KW, Chang PK, Smith GS. Hepatotumorigenicity and peroxisome proliferation induced by the hypolipidemic CI-924 in a two-year study in male and female B6C3F1 mice. Toxicol Pathol. 1996 May-Jun;24(3):265-72. PubMed PMID: 8736381. 4. Hofstra AH, King LM, Walker RM. Peroxisome proliferation and microsomal enzyme induction by the hypolipidemic CI-924 in rats and mice: relationship to tumorgenicity. Fundam Appl Toxicol. 1995 Sep;27(2):277-86. PubMed PMID: 8529824.